Navigation Links
NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009
Date:3/10/2009

RONKONKOMA, N.Y., March 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the B. Riley & Co. Annual Las Vegas Institutional Investor Conference on Wednesday, March 18, 2009.

The presentation is scheduled to be webcast live on the Company Web site, www.nbty.com, on Wednesday, March 18, 2009 at 1:00PM Pacific Time (4:00PM Eastern Time).

NBTY's preliminary unaudited net sales results for February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                             FOR THE MONTH OF FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $111      $81      38%

    North American Retail                     $17      $17       1%

    European Retail                           $42      $51     -18%

    Direct Response / E-Commerce              $17      $19     -10%

    Total                                    $187     $168      12%
                                             ====     ====      ===

Wholesale / US Nutrition net sales for the month of February 2009 include $33 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 3% for the one-month period. North American Retail same store sales increased 2% for the one month period. European Retail net sales for February 2009 include $7 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the period.

NBTY's preliminary unaudited net sales results for the two months January and February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                    FOR THE TWO MONTHS OF JANUARY AND FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $220     $164      34%

    North American Retail                     $34      $34       1%

    European Retail                           $88     $107     -18%

    Direct Response / E-Commerce              $38      $40      -6%

    Total                                    $380     $346      10%
                                             ====     ====      ===


Wholesale / US Nutrition net sales for the two-month period of January and February 2009 include $59 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 2% for the two-month period. North American Retail same store sales increased 2% for the two-month period. European Retail net sales for the two-month period of January and February 2009 include $15 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the two-month period.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) (www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact:  Harvey Kamil                            Carl Hymans
    NBTY, Inc.                                        G.S. Schwartz & Co.
    President & Chief Financial Officer               212-725-4500
    631-200-2020                                      carlh@schwartz.com

'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
2. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
3. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
4. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
5. Thoratec Presentation at Raymond James Conference to Be Webcast
6. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
7. Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results
8. Volcano Corporation Announces Webcast of February 25th Analyst Day
9. Telik Announces Year-End Financial Release, Conference Call and Webcast
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
11. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... of enhancements, upgrading their training and leads programs. , In February, 2017, Empower ... elite sales agents, Performance Partners is designed to teach how to maximize their ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... inspiring stories about real people of God in congregations across the United States. ... a Presbyterian minister ordained in 1964 who has served congregations in seven states ...
(Date:3/23/2017)... Alexandria, Virginia (PRWEB) , ... March 23, 2017 ... ... quality public health services to their communities, 16 more public health departments have ... This week’s decisions bring another 4.5 million people into the expanding network of ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Global Ampoules Market report provides ... applications and industry chain structure. The Ampoules market analysis ... competitive landscape analysis, and major regions, development status. ... ... providing 10 company profiles and 183 tables and figures ...
(Date:3/24/2017)... 2017  Eli Lilly and Company (NYSE: ... $850 million in its U.S. operations in 2017. ... enterprise, including research laboratories, manufacturing sites, and general ... by demand for Lilly products, as well as ... targeting cancer, pain, diabetes and other unmet medical ...
(Date:3/24/2017)... and GENEVA , March ... on World Tuberculosis Day revitalizes efforts to develop sutezolid ... On World Tuberculosis Day, TB Alliance and the ... the clinical development of sutezolid, an antibiotic drug candidate ... pertains to the development of sutezolid in combination with ...
Breaking Medicine Technology: